Clinical Trial Update: Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy [NA]

View source ↗

Summary

Completed clinical trial evaluating a novel dose adjustment algorithm to prevent cytopenia-related delays during FOLFOX chemotherapy; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Colorectal Cancer, Gastric Cancer | NA | Status: COMPLETED | Results posted: 2025-10-06